Mind Medicine (MindMed) Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 95.73 million compared to USD 56.8 million a year ago. Basic loss per share from continuing operations was USD 2.44 compared to USD 1.84 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.26 USD | +1.54% | -7.40% | +153.01% |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Mind Medicine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+153.01% | 666M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.34% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Mind Medicine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023